Literature DB >> 27363644

Equal distribution of mesenchymal stem cells after hepatic ischemia-reperfusion injury.

Askhat Isbambetov1, Zhassulan Baimakhanov2, Akihiko Soyama2, Masaaki Hidaka2, Yusuke Sakai2, Mitsuhisa Takatsuki2, Tamotsu Kuroki2, Susumu Eguchi3.   

Abstract

BACKGROUND: Liver ischemia-reperfusion (I/R) injury is one of the major causes of hepatocellular injury-related mortality and morbidity after liver transplantation. Mesenchymal stem cells (MSCs) have been shown to reduce liver I/R injury and improve regeneration. The purpose of the present study was to investigate the difference in the distribution of systemically delivered MSCs in the recipient's liver between the ischemic injury area and nonischemic area.
MATERIAL AND METHODS: Fishers' rats (7-8 week of age) were used as donors of MSCs and recipients. Bone marrow-derived MSCs were isolated from the donor's femur. Before systemic administration, MSCs were labeled with the fluorescent dye PKH26. The rats were divided into four groups: (1) I/R injury + MSC group, (2) MSC only, without I/R injury, (3) I/R injury + saline group, and (4) the Sham group. I/R injury was performed by clamping the inflow vascular structures of the left and middle lobes of the recipient's liver for 60 min. The right lobe was considered as a nonischemic part. Subsequently, 1.5 × 10(6) of MSCs or saline (NaCl, 0.9%) was administrated via the rat's tail vein. Thereafter, the rats were killed after days one, three, or seven for the analyses.
RESULTS: A fluorescent microscopy assay for labeled MSCs showed positive cells in both ischemic and nonischemic parts of the recipient's liver. The number of cells was significantly higher in the I/R injury + MSC group compared with the only MSC, without I/R injury group. Immunohistochemical staining showed that there was no significant difference in the proliferation of Ki-67-positive cells between the I/R + MSCs and I/R + saline groups. In addition, the serum transaminase levels were not different between the I/R + MSCs and I/R + saline groups.
CONCLUSIONS: After partial liver I/R injury, transplanted MSCs migrate equally to the ischemic and nonischemic parts of the recipient's liver. Considering the unique ability of the liver to regenerate, both parts of the liver presumably receive signals for regeneration.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BM-MSCs; I/R injury; Rat model; Transplantation

Mesh:

Substances:

Year:  2016        PMID: 27363644     DOI: 10.1016/j.jss.2016.03.057

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  Adipose-Derived Mesenchymal Stromal/Stem Cell Line Prevents Hepatic Ischemia/Reperfusion Injury in Rats by Inhibiting Inflammasome Activation.

Authors:  Kaili Chen; Hideaki Obara; Yumiko Matsubara; Kazumasa Fukuda; Hiroshi Yagi; Yukako Ono-Uruga; Kentaro Matsubara; Yuko Kitagawa
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

2.  Protective effects of heme oxygenase-1-transduced bone marrow-derived mesenchymal stem cells on reduced‑size liver transplantation: Role of autophagy regulated by the ERK/mTOR signaling pathway.

Authors:  Raorao Wang; Zhongyang Shen; Liu Yang; Mingli Yin; Weiping Zheng; Bin Wu; Tao Liu; Hongli Song
Journal:  Int J Mol Med       Date:  2017-09-06       Impact factor: 4.101

3.  Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury in rats.

Authors:  Yi Sun; Yang Wang; Liang Zhou; Yizhou Zou; Gengwen Huang; Ge Gao; Shi Ting; Xiong Lei; Xiang Ding
Journal:  Sci Rep       Date:  2018-02-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.